17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions
- Lymphoma
- Small Intestine Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: alvespimycin hydrochloride
Sponsor
National Institutes of Health Clinical Center (CC)
Collaborators